期刊文献+

融合蛋白基因与抗体基因电转染CHO-S细胞的条件摸索优化 被引量:2

Optimization of Electrotransfection Conditions of Genes for Fusion Protein and Antibody to CHO-S Cells
下载PDF
导出
摘要 旨在对编码融合蛋白和抗体的重组质粒转染CHO-S细胞的转染条件进行摸索优化,提高外源基因的转染效率,从而增加外源蛋白的表达。应用Amaxa Nucleofector-II电转仪,从电转染程序、质粒用量及细胞用量三方面着手,最终发现编码融合蛋白的重组质粒的最佳电转条件为:电转程序U-030,质粒用量20μg/孔,细胞用量1×10~7个/孔;编码抗体的重组质粒的最佳电转条件为:电转程序U-024,质粒用量15μg/孔,细胞用量1×10~7个/孔;实验结果进一步显示抗体重组质粒电转染CHO-S细胞的效果要优于融合蛋白重组质粒,利用高通量细胞筛选仪Clone Pix对转染后重组细胞的阳性克隆数进行统计,证实了该抗体重组质粒的转染效率更高。这为以后的抗体及融合蛋白重组质粒电转染CHO-S细胞提供了一定的数据支持,同时提示不同类型的细胞及外源基因,都需要设计相应的电转染实验进行条件优化,进而为获得高产稳定的生产用细胞株奠定基础。 The objective of this work is to optimize the conditions while recombinant plasmids encoding Fc-fusion protein and antibody transfect into CHO-S cells for improving the transfection efficiency and subsequently increasing the expression of exogenous proteins.The target genes were transfected into the CHO-S cells with Amaxa Nucleofector-II and the transfection conditions were screened from the 3 perspectives of electrotransfection programs,plasmid dosage and cell dosage.The optimized conditions for the Fc-fusion protein were found to be electroporation program U-030,plasmid dosage 20μg/well,and cell dosage 1×10^7 cells/well;while the optimized conditions for the antibody were electroporation program U-024,plasmid dosage 15μg/well,and cell dosage 1×10^7 cells/well.It was found that the transfection efficiency for the gene of the antibody was higher than that for the gene of Fc-fusion protein,which was also demonstrated by the ratio of positive clone analyzed with Clone Pix.This study provides data on electrotransfection of genes for antibody and Fc-fusion protein to CHO-S cells,also indicating that the importance of optimizing the electroporation conditions for different cell lines and target genes for obtaining stable and highyield producing cell lines.
作者 邓晓芬 杨晓佳 易天红 冯英 柯潇 赖维莉 DENG Xiao-fen;YANG Xiao-jia;YI Tian-hong;FENG Ying;KE Xiao;LAI Wei-li(Product Technology Center of Chengdu Kanghong Pharmaceuticals Group,Chengdu 610036)
出处 《生物技术通报》 CAS CSCD 北大核心 2019年第4期223-228,共6页 Biotechnology Bulletin
基金 "十三五"重大新药创制科技重大专项(2018ZX09733001-001-005)
关键词 融合蛋白 抗体 电转染 转染效率 fusion protein antibody electrotransfection transfection efficiency
  • 相关文献

参考文献7

二级参考文献77

  • 1Shou-LiangGong,GangZhao,Hong-GuangZhao,Wen-TianLü,Guang-WeiLiu,PingZhu.Ability of luteinizing hormone releasing hormone-Pseudomonas aeruginosa exotoxin 40 binding to LHRH receptor on human liver cancer cells[J].World Journal of Gastroenterology,2004,10(19):2870-2873. 被引量:8
  • 2Kohler G,Milstein C.Continuous cultures of fused cells secreting antibody of predefined specificity[J].Nature,1975,256(5517):495-497.
  • 3Vaughan T J,Williams A J,Pritchard K,et al.Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library[J].Nat Biotechnol,1996,14(3):309-314.
  • 4Winter G,Milstein C.Man-made antibodies[J].Nature,1991,349(6307):293-299.
  • 5Morrison S L,Johnson M J,Herzenberg L A.et al.Chimeric human antibody molecules-mouse antigen-binding domains with human constant region domains[J].Proc NatI head Sci,1984,81(21):6851-6855.
  • 6Adair J R.Engineering antibodies for therapy[J].Immunol Rev,1992,130:5-40.
  • 7Jones P T,Dear P H,Foote J,et al.Replacing the complementarity-determining regions in a human antibody with those from a mouse[J].Nature,1986,321(6069):522-525.
  • 8Verhoeyen M,Milstein C,Winter G.Reshaping human antibodies:grafting an antilysozyme activity[J].Science,1988,239(4847):1534-1536.
  • 9Kashmiri S V,de Pascalis R,Gonzales N R,et al.SDR grafting-a new approach to antibody humanization[J].Methods,2005,36(1):25-34.
  • 10Watanabe T S,Ohtori S,Koda M,et al.Adenoviral gene transfer in the peripheral nervous system[J].J Orthop Sci,2006,11(1):64-69.

共引文献41

同被引文献16

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部